Fundz
Real-time · AI · Cross-signal

Discover the power of real-time signals plus AI

Every contract, funding round, exec hire, and M&A move on Bluejay Diagnostics — with verified, ICP-scored contact reveals (email + mobile) on demand.

Trusted by founders, sales teams, recruiters, and investors at firms like BlackRock, Oracle, Kleiner Perkins, and HubSpot.

See plansBook a 15-min walkthrough
▶
Watch the 2-minute tour · with sound

Bluejay Diagnostics Announces Closing of $8.75 Million Underwritten Public Offering

Jun 28, 2024•almost 2 years ago

Contract Type

partnership

ActonHealthcareHealth Caremedical devices

Description

Bluejay Diagnostics, Inc. announced the closing of a firm commitment underwritten public offering with gross proceeds expected to be approximately $8.75 million. The company intends to use the net proceeds from the offering to repay $2.3 million and for general corporate purposes.

Company Information

Company

Bluejay Diagnostics

Location

360 MASSACHUSETTS AVENUE, SUITE 203

Acton, Massachusetts, United States

About

Bluejay Diagnostics, Inc. is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient product for triage and monitoring of disease progression.

Predictive Intelligence
Strategic

ML-powered predictions for Bluejay Diagnostics's next move

Learn about Strategic plan

Related People

Suggested for you

Sign in to view contact details

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months